HK1052303B - 含依匹那丁的溶液 - Google Patents

含依匹那丁的溶液

Info

Publication number
HK1052303B
HK1052303B HK03104651.9A HK03104651A HK1052303B HK 1052303 B HK1052303 B HK 1052303B HK 03104651 A HK03104651 A HK 03104651A HK 1052303 B HK1052303 B HK 1052303B
Authority
HK
Hong Kong
Prior art keywords
solutions containing
containing epinastine
epinastine
solutions
Prior art date
Application number
HK03104651.9A
Other languages
English (en)
Other versions
HK1052303A1 (en
Inventor
沃爾克‧特雷克
杰羅爾德‧杜施勒
Original Assignee
貝林格爾‧英格海姆國際有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7928843&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1052303(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 貝林格爾‧英格海姆國際有限公司 filed Critical 貝林格爾‧英格海姆國際有限公司
Publication of HK1052303A1 publication Critical patent/HK1052303A1/xx
Publication of HK1052303B publication Critical patent/HK1052303B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F01—MACHINES OR ENGINES IN GENERAL; ENGINE PLANTS IN GENERAL; STEAM ENGINES
    • F01L—CYCLICALLY OPERATING VALVES FOR MACHINES OR ENGINES
    • F01L9/00—Valve-gear or valve arrangements actuated non-mechanically
    • F01L9/20—Valve-gear or valve arrangements actuated non-mechanically by electric means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T137/00—Fluid handling
    • Y10T137/0318—Processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Mechanical Engineering (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Detergent Compositions (AREA)
HK03104651.9A 1999-11-12 2003-06-30 含依匹那丁的溶液 HK1052303B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19954516A DE19954516A1 (de) 1999-11-12 1999-11-12 Epinastin-haltige Lösungen
PCT/EP2000/010122 WO2001035962A1 (de) 1999-11-12 2000-10-14 Epinastin-haltige lösungen

Publications (2)

Publication Number Publication Date
HK1052303A1 HK1052303A1 (en) 2003-09-11
HK1052303B true HK1052303B (zh) 2007-04-13

Family

ID=7928843

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03104651.9A HK1052303B (zh) 1999-11-12 2003-06-30 含依匹那丁的溶液

Country Status (40)

Country Link
US (6) US20030050303A1 (zh)
EP (1) EP1231920B1 (zh)
JP (1) JP2003514021A (zh)
KR (1) KR100758842B1 (zh)
CN (1) CN1292752C (zh)
AR (1) AR026424A1 (zh)
AT (1) ATE353218T1 (zh)
AU (2) AU784017B2 (zh)
BG (1) BG65775B1 (zh)
BR (1) BR0015477A (zh)
CA (1) CA2391076C (zh)
CO (1) CO5251448A1 (zh)
CY (1) CY1106375T1 (zh)
CZ (1) CZ302483B6 (zh)
DE (2) DE19954516A1 (zh)
DK (1) DK1231920T3 (zh)
EA (1) EA006937B1 (zh)
EE (1) EE05395B1 (zh)
ES (1) ES2281359T3 (zh)
HK (1) HK1052303B (zh)
HR (1) HRP20020404B1 (zh)
HU (1) HU229502B1 (zh)
IL (2) IL149501A0 (zh)
ME (1) MEP36708A (zh)
MX (1) MXPA02004556A (zh)
MY (1) MY130441A (zh)
NO (1) NO329417B1 (zh)
NZ (1) NZ519425A (zh)
PE (1) PE20010826A1 (zh)
PL (1) PL198879B1 (zh)
PT (1) PT1231920E (zh)
RS (1) RS50173B (zh)
SA (1) SA01210658B1 (zh)
SI (1) SI1231920T1 (zh)
SK (1) SK287343B6 (zh)
TR (1) TR200201270T2 (zh)
TW (1) TWI225401B (zh)
UA (1) UA74563C2 (zh)
WO (1) WO2001035962A1 (zh)
ZA (1) ZA200203683B (zh)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
MXPA05000071A (es) * 2002-08-02 2005-04-08 Boehringer Ingelheim Int Combinaciones de epinastina, pseudoefedrina y metilefedrina como nuevas formulaciones farmaceuticas.
EP1468696A1 (en) * 2003-04-17 2004-10-20 Boehringer Ingelheim International GmbH Combinations of epinastine and antiphlogisitcs as new pharmaceutical compositions for the treatment of skin diseases
US20040247686A1 (en) * 2003-04-04 2004-12-09 Boehringer Ingelheim International Gmbh Pharmaceutical compositions comprising epinastine for the treatment of skin diseases
US20060073172A1 (en) * 2004-10-01 2006-04-06 Schneider L W Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure
EP1901724A1 (en) * 2005-07-08 2008-03-26 Senju Pharmaceutical Co., Ltd. Percutaneously absorptive ophthalmic preparation comprising epinastine
WO2008098122A2 (en) * 2007-02-08 2008-08-14 Inspire Pharmaceuticals, Inc. Method for treating allergic rhinitis without adverse effects
US7378082B1 (en) 2007-11-05 2008-05-27 Inspire Pharmaceuticals, Inc. Method for treating allergic rhinitis without adverse effects
US20080194544A1 (en) * 2007-02-08 2008-08-14 Ramesh Krishnamoorthy Aqueous formulations of epinastine for treating allergic rhinitis
EP2464387A4 (en) * 2009-08-12 2013-05-15 Seros Medical Llc DEUTERATED WATER SOLUTION AND RIBOFLAVIN FOR EXTENDED OXYGEN SINGULET LIFETIME IN THE TREATMENT OF OCULAR TISSUE AND METHOD OF USE
TWI544922B (zh) 2011-05-19 2016-08-11 愛爾康研究有限公司 高濃度歐羅派特錠（ｏｌｏｐａｔａｄｉｎｅ）眼用組成物
EP2630952A1 (en) * 2012-02-23 2013-08-28 Novagali Pharma S.A. Self-preserved oil dispersions comprising boric acid
CA2894170C (en) * 2012-12-19 2021-08-10 Sarcode Bioscience Inc. Lfa-1 inhibitor formulations
CN104491876A (zh) * 2014-12-23 2015-04-08 中国药科大学 含玻璃酸钠的依匹斯汀滴眼液及其制备方法
ITUB20153950A1 (it) * 2015-09-28 2017-03-28 Tred Srl Dispositivo nasale in grado di attivare il riflesso rino-palatale per l'igienizzazione rinofaringea
JP6134853B1 (ja) * 2016-10-28 2017-05-24 参天製薬株式会社 エピナスチン含有点眼液
JP6635974B2 (ja) * 2017-04-24 2020-01-29 参天製薬株式会社 エピナスチン含有点眼液
TW201841620A (zh) * 2017-05-01 2018-12-01 日商參天製藥股份有限公司 點眼劑
JP2019108320A (ja) * 2018-10-31 2019-07-04 参天製薬株式会社 ソフトコンタクトレンズの変質を抑制する眼科用組成物
JP6736752B2 (ja) * 2019-12-17 2020-08-05 参天製薬株式会社 エピナスチン含有点眼液
JP6963651B2 (ja) * 2020-04-16 2021-11-10 参天製薬株式会社 エピナスチン又はその塩を含有する水性組成物
JP7118579B1 (ja) 2020-04-16 2022-08-16 参天製薬株式会社 エピナスチン又はその塩を含有する水性組成物
JP2020169213A (ja) * 2020-07-15 2020-10-15 参天製薬株式会社 エピナスチン含有点眼液
CN115448927A (zh) * 2022-10-20 2022-12-09 重庆瑞泊莱医药科技有限公司 一种氢溴酸依匹斯汀晶型ii及其制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US203021A (en) * 1878-04-30 Improvement in side-bar wagons
US181478A (en) * 1876-08-22 Improvement in water-wheels
US228359A (en) * 1880-06-01 jones
US104017A (en) * 1870-06-07 Improvement in embroidering attachment for sewing-machines
US151541A (en) * 1874-06-02 Improvement in hay-loaders
US8632A (en) * 1852-01-06 George hess
US215396A (en) * 1879-05-13 Improvement in loom-temples
DE3008944A1 (de) * 1980-03-08 1981-09-24 C.H. Boehringer Sohn, 6507 Ingelheim Dibenzimidazoazepine, ihre herstellung und verwendung
DE4102148A1 (de) * 1991-01-25 1992-07-30 Boehringer Ingelheim Kg Verfahren zur herstellung von 3-amino-9,13b-dihydro-1h-dibenz-(c,f)imidazol(1,5-a)azepin-hydrochlorid
US5668133A (en) * 1992-12-09 1997-09-16 Alcon Laboratories, Inc. Ophthalmic compositions comprising emedastine and methods for their use
TR199701711T1 (xx) * 1995-06-27 1998-05-21 Boehringer Ingelheim Kg. Aerosollerin imalat� i�in yeni stabil ila� bile�imleri.
DE19542281C2 (de) * 1995-11-14 1997-12-04 Boehringer Ingelheim Kg Verwendung von Epinastin für die Behandlung der Migräne
AU3869197A (en) * 1996-08-30 1998-03-19 Kyoto Pharmaceutical Industries, Ltd. Remedies for allergic dermatitis
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
US20030215396A1 (en) * 1999-09-15 2003-11-20 Boehringer Ingelheim Pharma Kg Method for the production of propellant gas-free aerosols from aqueous medicament preparations
EP0903151A1 (en) * 1997-09-22 1999-03-24 ASTA Medica Aktiengesellschaft Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
PL355101A1 (en) * 1999-11-18 2004-04-05 Alcon Inc. Use of h1
DE19958460A1 (de) * 1999-12-03 2001-06-07 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Epinastine-Hydrochlorid in der hochschmelzenden Kristallmodifikation
FR2803520B1 (fr) * 2000-01-12 2002-09-20 Ceva Sante Animale Procede pour augmenter la production d'oeufs et consolider la coquille des oeufs chez les volailles
US20020094345A1 (en) * 2000-10-06 2002-07-18 Sara Abelaira Pharmaceutical compositions containing epinastine and pseudoephedrine
US20020151541A1 (en) * 2000-10-31 2002-10-17 Michel Pairet Pharmaceutical compositions containing tiotropium salts and antihistamines and their use
US20020137764A1 (en) * 2000-10-31 2002-09-26 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
DE10119718A1 (de) * 2001-04-21 2002-10-31 Boehringer Ingelheim Pharma Verfahren zur kontinuierlichen Herstellung inhalierfähiger Arzneistoffe, Vorrichtung zur Durchführung des Verfahrens und nach diesem Verfahren hergestellter Arzneistoff
AU2002305780A1 (en) * 2001-05-29 2002-12-09 Transchip, Inc. Patent application cmos imager for cellular applications and methods of using such
US20030104017A1 (en) * 2001-10-26 2003-06-05 Boehringer Ingelheim International Gmbh Epinastine formulation for oral administration
EP1350512A1 (en) * 2002-04-03 2003-10-08 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Combinations of epinastine, belladonna and pseudoephedrine as new pharmaceutical formulations
US6863848B2 (en) * 2002-08-30 2005-03-08 Signet Armorlite, Inc. Methods for preparing composite photochromic ophthalmic lenses
JP2007145316A (ja) * 2005-10-27 2007-06-14 Nissan Motor Co Ltd 遮光装置とサンバイザーとサンルーフユニット

Also Published As

Publication number Publication date
HUP0203773A3 (en) 2005-01-28
CY1106375T1 (el) 2011-10-12
NO329417B1 (no) 2010-10-18
TR200201270T2 (tr) 2002-12-23
MY130441A (en) 2007-06-29
MXPA02004556A (es) 2004-09-10
BG65775B1 (bg) 2009-11-30
NO20022201D0 (no) 2002-05-08
TWI225401B (en) 2004-12-21
MEP36708A (en) 2011-02-10
UA74563C2 (uk) 2006-01-16
IL149501A0 (en) 2002-11-10
CN1390129A (zh) 2003-01-08
NO20022201L (no) 2002-05-08
JP2003514021A (ja) 2003-04-15
DK1231920T3 (da) 2007-04-10
HK1052303A1 (en) 2003-09-11
EA006937B1 (ru) 2006-06-30
KR20020050273A (ko) 2002-06-26
ATE353218T1 (de) 2007-02-15
RS50173B (sr) 2009-05-06
CA2391076A1 (en) 2001-05-25
US20050288274A1 (en) 2005-12-29
HRP20020404B1 (en) 2007-08-31
IL149501A (en) 2012-04-30
BG106681A (en) 2002-12-29
EA200200492A1 (ru) 2002-10-31
NZ519425A (en) 2004-04-30
SK287343B6 (sk) 2010-07-07
HRP20020404A2 (en) 2004-08-31
HUP0203773A2 (hu) 2003-03-28
EE200200246A (et) 2003-06-16
AR026424A1 (es) 2003-02-12
EP1231920B1 (de) 2007-02-07
EE05395B1 (et) 2011-04-15
CZ302483B6 (cs) 2011-06-08
SI1231920T1 (sl) 2007-06-30
PL198879B1 (pl) 2008-07-31
AU784017B2 (en) 2006-01-12
US20030050303A1 (en) 2003-03-13
AU1138101A (en) 2001-05-30
CO5251448A1 (es) 2003-02-28
PE20010826A1 (es) 2001-08-20
CA2391076C (en) 2008-06-17
US20080009476A1 (en) 2008-01-10
ES2281359T3 (es) 2007-10-01
US20090239842A1 (en) 2009-09-24
BR0015477A (pt) 2002-06-25
WO2001035962A1 (de) 2001-05-25
CZ20021956A3 (cs) 2002-08-14
CN1292752C (zh) 2007-01-03
EP1231920A1 (de) 2002-08-21
PT1231920E (pt) 2007-03-30
KR100758842B1 (ko) 2007-09-19
SA01210658B1 (ar) 2006-11-05
AU2006201541A1 (en) 2006-05-11
YU33602A (sh) 2005-03-15
DE19954516A1 (de) 2001-05-17
DE50014041D1 (de) 2007-03-22
US20070185082A1 (en) 2007-08-09
PL364028A1 (en) 2004-11-29
HU229502B1 (en) 2014-01-28
US7429602B2 (en) 2008-09-30
ZA200203683B (en) 2003-09-03
US20070197503A1 (en) 2007-08-23
SK8302002A3 (en) 2002-09-10

Similar Documents

Publication Publication Date Title
HK1052303A1 (en) Solutions containing epinastine
AU138704S (en) Watch
EP1216935A4 (en) CASING
AU141168S (en) Watch
GB9903377D0 (en) Amphibious-tricycle (amphi-trike)
GB9905498D0 (en) Expression
GB2357346B (en) Timepiece
GB0027081D0 (en) Solution
IL144237A0 (en) Organoprotective solutions
GB2347237B (en) Timepiece
CA88114S (en) Carrying case
TW413337U (en) Improved eyeglass structure
TW402108U (en) Improved glasses structure
GB9918373D0 (en) Molliboard (floodbarrier)
GB9919326D0 (en) Case
AU142326S (en) Case
AU141042S (en) Case
GB9911746D0 (en) Speitze can
AU137240S (en) Can
AU140315S (en) Spectacles
TW400955U (en) Spectacles
AU140655S (en) Watch
AU142592S (en) Watch
AU141830S (en) Watch
AU141831S (en) Watch

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20201013